portfolio
Prexton Therapeutics
Prexton Therapeutics has the mission to develop innovative drugs to improve the quality of life of people who suffer from Parkinson’s disease and other brain disorders. Prexton Therapeutics has the expertise to design novel mGluR4 compounds as new treatment for Parkinson’s disease.
Details
Prexton Therapeutics
14 chemin des Aulx
1228 Plan les Ouates, Geneva
Switzerland
www.prextontherapeutics.com
